Migraine (Adult) Clinical Trials

A listing of Migraine (Adult) medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

California

Pharmacology Research Institute, Encino
Encino California 91316

BHV3000-301: Phase 3: Double-Blind, Randomized, Placebo Controlled, Safety and Efficacy, Trial of BHV-3000 (rimegepant) for the Acute Treatment of Migraine

Sun Valley Research Center
Imperial California 92251

Adult patients with migraine attacks with moderate headache pain.

Pharmacology Research Institute - Los Alamitos
Los Alamitos California 90720

BHV3000-302: Phase 3: Double-Blind, Randomized, Placebo Controlled, Safety and Efficacy, Trial of BHV-3000 (rimegepant) for the Acute Treatment of Migraine

Pharmacology Research Institute - Newport Beach
Newport Beach California 92660

BHV3000-302: Phase 3: Double-Blind, Randomized, Placebo Controlled, Safety and Efficacy, Trial of BHV-3000 (rimegepant) for the Acute Treatment of Migraine

Minnesota

Clinical Research Institute, MN
Minneapolis Minnesota 55402

926_Migraine Headache Research Study for Adults

Missouri

New York

Biomedical Research Alliance of New York
Bronx New York 10461

BHV-3000 in Patients with Acute Migraines

North Carolina

North Carolina Clinical Research
Raleigh North Carolina 27607

Migraine Headache Clinical Research Study

South Carolina

Coastal Carolina Research Center
Mount Pleasant South Carolina 29464

A Parallel Group, Double-Blind, Randomized, Placebo Controlled Phase 3 Trial to Evaluate the Efficacy and Safety of ALD403 Administered Intravenously in Patients With Chronic Migraine

Coastal Carolina Research Center
Mount Pleasant South Carolina 29464

A Phase 2/3, Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel-Group Study To Evaluate The Efficacy, Safety, And Tolerability Of Multiple Dosing Regimens Of Oral AGN-241689 In Episodic Migraine Prevention

Coastal Carolina Research Center
Mount Pleasant South Carolina 29464

Efficacy, Tolerability, and Safety of DFN-15

Washington

Northwest Clinical Research Center
Bellevue Washington 98007

A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBOCONTROLLED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF MULTIPLE DOSING REGIMENS OF ORAL AGN-241689 IN EPISODIC MIGRAINE PREVENTION

Northwest Clinical Research Center
Bellevue Washington 98007

Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (rimegepant) for the Acute Treatment of Migraine